1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications

6 US Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 US Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 US Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 US Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast

8 Competitive Landscape
8.1 Competitive Structure
8.2 Key Players
8.3 Profiles of Key Players

List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: US: Overweight & Obese Population (in Million), 2011, 2018 & 2024
Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 6: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+, in %), 2018
Figure 7: US: Diabetes Prevalence by Age Groups (in %), 2018
Figure 8: US: Total Number of Diabetes Patients (in ‘000), 2011-2018
Figure 9: US: Total Number of Diabetes Patients Forecast (in ‘000), 2019-2024
Figure 10: US (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 11: US (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 12: US (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011 -2018
Figure 13: US (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 14: US (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 15: US (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 16: US: Total Number of Diabetes Patients by Age Group (20-39, 40-59 & 60-79, in ‘000), 2011-2018
Figure 17: US: Total Number of Diabetes Patients by Age Group (20-39, 40-59 & 60-79, in ‘000), 2019-2024
Figure 18: US: Diabetes Drug Industry Overview
Figure 19: US: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 20: US: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 21: US: Diabetes Drug Market: SWOT Analysis
Figure 22: US: Diabetes Drug Market: Value Chain Analysis
Figure 23: US: Diabetes Drug Market: Porters Five Forces Analysis
Figure 24: US: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 25: US: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 26: US: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 27: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 28: US: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 29: US: Oral Antidiabetics Market: Sales Value (in Million US$), 2019-2024
Figure 30: US: Insulin Market, (in Million US$), 2011-2018
Figure 31: US: Breakup of Insulin Market by Class (in %), 2018
Figure 32: US: Insulin Market: Sales Share of Key Players (in %)
Figure 33: US: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 & 2024
Table 3: US: Overweight & Obesity Statistics, 2011, 2018 & 2024
Table 4: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+, in Million)
Table 5: US: Total Prevalence & Number of Diabetes Patients (in ‘000), 2011, 2018 & 2024
Table 6: US (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in ‘000), 2011, 2018 & 2024
Table 7: US (Urban & Rural): Total Prevalence & Number of Diabetes Patients (in ‘000), 2011, 2018 & 2024
Table 8: US (Male & Female): Total Prevalence & Number of Diabetes Patients (in ‘000), 2011, 2018 & 2024
Table 9: US: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59 & 60-79, in ‘000), 2011, 2018 & 2024
Table 10: US: Diabetes Drug Market: Competitive Structure
Table 11: US: Diabetes Drug Market: Key Players